GENFIT Share Price Other OTC
Stocks
GNFTF
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded
| Market Cap | 52Cr 59Cr 48Cr 45Cr 84Cr 5.59TCr 85Cr 567.9Cr 220.09Cr 2.75TCr 222.53Cr 217.75Cr 9.56TCr | P/E 2025 |
-3.06x | P/E 2026 * | 54.6x |
|---|---|---|---|---|---|
| Enterprise Value | 46Cr 53Cr 43Cr 40Cr 75Cr 5TCr 76Cr 507.78Cr 196.79Cr 2.46TCr 198.97Cr 194.7Cr 8.55TCr | EV / Sales 2025 |
2.34x | EV / Sales 2026 * | 4.94x |
| Free-Float |
86.88% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -3.28% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.28% | -.--% | - | - | 59Cr | |
| +1.44% | +1.71% | -10.63% | -9.16% | 4.27TCr | |
| +0.37% | +9.22% | +308.19% | +562.02% | 3.47TCr | |
| +2.84% | +3.80% | +6.87% | +34.93% | 3TCr | |
| -1.70% | -7.34% | +8.51% | -22.34% | 2.8TCr | |
| -1.90% | +2.47% | +10.18% | +18.13% | 2.48TCr | |
| +1.22% | +7.06% | - | - | 1.43TCr | |
| +0.68% | -3.13% | +52.04% | +107.47% | 1.31TCr | |
| -0.57% | -2.43% | +5.18% | +4.20% | 1.26TCr | |
| -0.26% | +0.41% | +100.27% | +80.69% | 1.22TCr | |
| Average | +0.03% | +0.55% | +60.08% | +96.99% | 2.36TCr | |
| Weighted average by Cap. | +0.73% | +0.91% | +65.06% | +113.03% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 6.68Cr 7.66Cr 6.19Cr 5.79Cr 11Cr 723.09Cr 11Cr 73Cr 28Cr 355.91Cr 29Cr 28Cr 1.24TCr | 9.52Cr 11Cr 8.82Cr 8.25Cr 15Cr 1.03TCr 16Cr 104.59Cr 41Cr 507.09Cr 41Cr 40Cr 1.76TCr |
| Net income | -83.02L -95.22L -76.89L -71.98L -1.35Cr -90Cr -1.36Cr -9.12Cr -3.54Cr -44Cr -3.57Cr -3.5Cr -153.56Cr | 1.83Cr 2.1Cr 1.7Cr 1.59Cr 2.98Cr 198.11Cr 2.99Cr 20Cr 7.8Cr 98Cr 7.88Cr 7.71Cr 338.59Cr |
| Net Debt | -5.47Cr -6.28Cr -5.07Cr -4.74Cr -8.9Cr -592.18Cr -8.95Cr -60Cr -23Cr -291.48Cr -24Cr -23Cr -1.01TCr | -4.69Cr -5.38Cr -4.34Cr -4.06Cr -7.62Cr -507.2Cr -7.67Cr -51Cr -20Cr -249.65Cr -20Cr -20Cr -866.86Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
